Desensitization, Immunologic
"Desensitization, Immunologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity.
Descriptor ID |
D003888
|
MeSH Number(s) |
E02.095.465.425.450.310 E05.478.610.310
|
Concept/Terms |
Desensitization, Immunologic- Desensitization, Immunologic
- Immunologic Desensitization
- Desensitizations, Immunologic
- Immunologic Desensitizations
- Therapy, Hyposensitization
- Hyposensitization Therapies
- Therapies, Hyposensitization
- Hyposensitization Therapy
Allergen Immunotherapy- Allergen Immunotherapy
- Allergen Immunotherapies
- Immunotherapies, Allergen
- Immunotherapy, Allergen
|
Below are MeSH descriptors whose meaning is more general than "Desensitization, Immunologic".
Below are MeSH descriptors whose meaning is more specific than "Desensitization, Immunologic".
This graph shows the total number of publications written about "Desensitization, Immunologic" by people in this website by year, and whether "Desensitization, Immunologic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 1 | 2 |
2004 | 0 | 1 | 1 |
2009 | 1 | 1 | 2 |
2010 | 2 | 0 | 2 |
2011 | 2 | 0 | 2 |
2012 | 2 | 0 | 2 |
2013 | 1 | 0 | 1 |
2014 | 3 | 0 | 3 |
2015 | 2 | 0 | 2 |
2018 | 1 | 0 | 1 |
2020 | 0 | 2 | 2 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Desensitization, Immunologic" by people in Profiles.
-
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results. J Allergy Clin Immunol Pract. 2022 07; 10(7):1864-1873.e10.
-
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study. J Allergy Clin Immunol Pract. 2021 05; 9(5):1879-1889.e13.
-
Aspirin-exacerbated respiratory disease: personalized medical and surgical approaches. Int Forum Allergy Rhinol. 2020 09; 10(9):1035-1036.
-
AR101 Oral Immunotherapy for Peanut Allergy. N Engl J Med. 2018 Nov 22; 379(21):1991-2001.
-
Rapid oral desensitization to sirolimus in a patient with lymphangioleiomyomatosis. J Allergy Clin Immunol Pract. 2016 Mar-Apr; 4(2):352-3.
-
The efficacy assessment of a self-administered immunotherapy protocol. Int Forum Allergy Rhinol. 2016 Feb; 6(2):148-55.
-
The safety of self-administered allergen immunotherapy during the buildup and maintenance phases. Int Forum Allergy Rhinol. 2015 Feb; 5(2):149-56.
-
Editorial: Studying the spectrum of allergic and rhinologic disease. Am J Rhinol Allergy. 2014 Nov-Dec; 28(6):447-8.
-
Systematic review of immunotherapy for chronic rhinosinusitis. Am J Rhinol Allergy. 2014 Mar-Apr; 28(2):145-50.
-
A 1-day imported fire ant rush immunotherapy schedule with and without premedication. Ann Allergy Asthma Immunol. 2013 Dec; 111(6):562-6.